DBV Technologies S.A. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
DBV Receives Non Approval Letter From FDA For Peanut Allergy Patch
Article By: The Fly
Tuesday, August 4, 2020 5:25 AM EDT
DBV Technologies announced that the Food and Drug Administration has issued a Complete Response Letter regarding the company's Biologics License Application for Viaskin Peanut.
In this article: DBVT
Read
DBV Jumps 41% To $9.96 After Update On Viaskin Peanut Filing
Article By: The Fly
Wednesday, February 13, 2019 5:49 PM EDT
Shares of DBV Technologies jumped after the company said that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut is anticipated in the third quarter of 2019.
In this article: DBVT Also: AIMT
Read
DBV Technologies - All Time High
Article By: Jim Van Meerten
Wednesday, July 8, 2015 3:22 PM EDT
DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut.
In this article: DBVT
Read
Thursday Morning Pre-Market Insights: EXAS, AVEO, ONTY, DBVT
Article By: TipRanks
Thursday, June 4, 2015 8:33 AM EDT
Thursday morning pre-market insights: EXAS, AVEO, ONTY, DBVT.
In this article: ONTY, AVEO, EXAS, DBVT
Read

Latest Tweets for $DBVT

No tweets yet!